Printer Friendly
The Free Library
22,728,043 articles and books

CLINICAL STUDY OPENINGS.



An investigational drug for treating bipolar I Bipolar I is a sub-diagnosis of bipolar disorder. Diagnosis of Bipolar I requires at least one Manic or Mixed episode, but there may be episodes of Hypomania or Major Depression as well. (This diagnosis conforms to the classic concept of manic depressive illness.  is now being studied at Indiana University Hospital Indiana University Hospital is a teaching hospital in Indianapolis, Indiana affiliated with the Indiana University School of Medicine and Clarian Health Partners. As part of Clarian, the hospital works closely with nearby Methodist Hospital and James Whitcomb Riley Hospital for Children.  in Indianapolis. To qualify, you must be 18 years of age or older, have a diagnosis of bipolar I disorder, and not have active seizures In counterdrug operations, includes drugs and conveyances seized by law enforcement authorities and drug-related assets (monetary instruments, etc.) confiscated based on evidence that they have been derived from or used in illegal narcotics activities. , heart disease, or other serious or unstable illnesses.

The safety and effectiveness of the new drug will be evaluated during the 13-month study. Qualified volunteers will receive compensation for time and travel, psychiatric evaluation psychiatric evaluation The assessment of a person's mental, social, psychologic functionality. See DSM-IV-table multiaxial assessment, Personality testing, Psychiatric history, Psychiatric interview.  and testing, and free study-related testing. For more information, Indiana residents may call 317-278-0038.
COPYRIGHT 2001 Benjamin Franklin Literary & Medical Society, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Medical Update
Date:Mar 1, 2001
Words:88
Previous Article:CHILDHOOD OBESITY: A "BIG" PROBLEM.
Next Article:MEDICAL PROGRESS.
Topics:



Related Articles
OMAPATRILAT REDUCES RISK FOR CONGESTIVE HEART FAILURE PATIENT.
NIH opens doors of hospital dedicated to clinical research.
New clinical research hospital.
Disaster nursing and emergency preparedness for chemical, biological, and radiological terrorism and other hazards, 2d ed.
Milk thistle may protect liver of children receiving chemo.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters